Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04281069Completed

Diabetes Type 2 in the Eastern Region of Morocco

Role: collaborator

NCT04635332Not ApplicableCompleted

Food Literacy and Physical Activity Intervention to Optimize Metabolic Health Among Women in Urban Uganda

Role: collaborator

NCT04733690Unknown

METABOLIC CHARACTERISTICS OF A NOVEL COMMON BEAN PRODUCT

Role: collaborator

NCT02438774Not ApplicableCompleted

Intervention in Minimizing Aflatoxins and Fumonisins Exposure to Children Through Food and Breastfeeding in Tanzania

Role: collaborator

All 4 trials loaded